Pyxis Oncology prices USD 50 million private placement at USD 2.55 a share

Pyxis Oncology, Inc.

Pyxis Oncology, Inc.

PYXS

0.00
  • Pyxis Oncology priced a private placement expected to raise about USD 50 million in gross proceeds.
  • Deal includes 19,600,153 common shares at USD 2.55 each.
  • Investors also received warrants for 19,600,153 shares at an exercise price of USD 3.29, adding about USD 64 million if fully exercised.
  • Proceeds expected to extend cash runway into Q2 2027, funding further MICVO clinical follow-up.
  • Closing expected around July 2, 2026, subject to customary conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pyxis Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606300730PRIMZONEFULLFEED9754676) on June 30, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.